Understanding the role of interactions between host and Mycobacterium tuberculosis under hypoxic condition: An in silico approach

BMC Genomics

Volumn 19, Issue 1, 2018, Pages

  Bose, Tungadri ^a,b   Das, Chandrani ^a,b   Dutta, Anirban ^a   Mahamkali, Vishnuvardhan ^a,c   Sadhu, Sudipta ^a   Mande, Sharmila S ^a  

^a TATA CONSULTANCY SERVICES   (India)

^b INDIAN INSTITUTE OF TECHNOLOGY BOMBAY   (India)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Flux balance analysis; Gene regulatory network; Genome scale metabolic model; Host pathogen interactions; Hypoxia; Mycobacterium tuberculosis infection

Indexed keywords

REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; BACTERIAL PROTEIN;

ARTICLE; BACTERIAL METABOLISM; CELL CYCLE; CELL SURVIVAL; COMPUTER MODEL; CONTROLLED STUDY; CYTOSKELETON; EVOLUTIONARY ADAPTATION; GENE CONTROL; GENE REGULATORY NETWORK; HOST PATHOGEN INTERACTION; HUMAN; HYPOXIA; MYCOBACTERIUM TUBERCULOSIS; NITRATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; CELL HYPOXIA; COMPUTER SIMULATION; GENETICS; MACROPHAGE; METABOLISM; MICROBIOLOGY; PROTEIN ANALYSIS;

BACTERIAL PROTEINS; CELL HYPOXIA; COMPUTER SIMULATION; GENE REGULATORY NETWORKS; HOST-PATHOGEN INTERACTIONS; HUMANS; MACROPHAGES; MYCOBACTERIUM TUBERCULOSIS; PROTEIN INTERACTION MAPPING;

EID: 85050616156     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/s12864-018-4947-8     Document Type: Article

References (51)

1. Escoll P, Rolando M, Buchrieser C. Modulation of host autophagy during bacterial infection: sabotaging host munitions for pathogen nutrition. Front Immunol. 2016;7:81.
2. Mukherjee S, Sambarey A, Prashanthi K, Chandra N. Current trends in modeling host-pathogen interactions. Wiley Interdiscip Rev Data Min Knowl Discov. 2013;3:109-28.
3. Casadevall A, Pirofski LA. Host-pathogen interactions: basic concepts of microbial commensalism, colonization, infection, and disease. Infect Immun. 2000;68:6511-8.
4. Lillebaek T, Dirksen A, Baess I, Strunge B, Thomsen VØ, Andersen AB. Molecular evidence of endogenous reactivation of Mycobacterium tuberculosis after 33 years of latent infection. J Infect Dis. 2002;185:401-4.
5. Parrish NM, Dick JD, Bishai WR. Mechanisms of latency in Mycobacterium tuberculosis. Trends Microbiol. 1998;6:107-12.
6. Warner DF, Mizrahi V. The survival kit of Mycobacterium tuberculosis. Nat Med. 2007;13:282-4.
7. Park H-D, Guinn KM, Harrell MI, Liao R, Voskuil MI, Tompa M, et al. Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis. Mol Microbiol. 2003;48:833-43.
8. Rustad TR, Harrell MI, Liao R, Sherman DR. The enduring hypoxic response of Mycobacterium tuberculosis. PLoS One. 2008;3:e1502.
9. Sherman DR, Voskuil M, Schnappinger D, Liao R, Harrell MI, Schoolnik GK. Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha -crystallin. Proc Natl Acad Sci U S A. 2001;98:7534-9.
10. Zhou H, Gao S, Nguyen NN, Fan M, Jin J, Liu B, et al. Stringent homology-based prediction of H. sapiens-M. tuberculosis H37Rv protein-protein interactions. Biol Direct. 2014;9:5.
11. Bermudez LE, Goodman J. Mycobacterium tuberculosis invades and replicates within type II alveolar cells. Infect Immun. 1996;64:1400-6.
12. García-Pérez BE, De la Cruz-López JJ, Castañeda-Sánchez JI, Muñóz-Duarte AR, Hernández-Pérez AD, Villegas-Castrejón H, et al. Macropinocytosis is responsible for the uptake of pathogenic and non-pathogenic mycobacteria by B lymphocytes (Raji cells). BMC Microbiol. 2012;12:246.
13. Dayaram YK, Talaue MT, Connell ND, Venketaraman V. Characterization of a glutathione metabolic mutant of Mycobacterium tuberculosis and its resistance to glutathione and nitrosoglutathione. J Bacteriol. 2006;188:1364-72.
14. Bułdak RJ, Bułdak Ł, Polaniak R, Kukla M, Birkner E, Kubina R, et al. Visfatin affects redox adaptative responses and proliferation in Me45 human malignant melanoma cells: an in vitro study. Oncol Rep. 2013;29:771-8.
15. Kim K-W, Lee H-J. Composition comprising expression or activity inhibitors of ninjurin 1 for the prevention and treatment of inflammatory disease. 2011. Available from: http://www.google.com/patents/US20110123538 [cited 12 May 2017]
16. Dong Y, Demaria S, Sun X, Santori FR, Jesdale BM, De Groot AS, et al. HLA-A2-restricted CD8+-cytotoxic-T-cell responses to novel epitopes in Mycobacterium tuberculosis superoxide dismutase, alanine dehydrogenase, and glutamine synthetase. Infect Immun. 2004;72:2412-5.
17. Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017;45:D353-61.
18. Galagan JE, Minch K, Peterson M, Lyubetskaya A, Azizi E, Sweet L, et al. The Mycobacterium tuberculosis regulatory network and hypoxia. Nature. 2013;499:178-83.
19. Hegde SR, Rajasingh H, Das C, Mande SS, Mande SC. Understanding communication signals during mycobacterial latency through predicted genome-wide protein interactions and Boolean modeling. PLoS One. 2012;7:e33893.
20. Bartek IL, Woolhiser LK, Baughn AD, Basaraba RJ, Jacobs WR, Lenaerts AJ, et al. Mycobacterium tuberculosis Lsr2 is a global transcriptional regulator required for adaptation to changing oxygen levels and virulence. mBio. 2014;5:e01106-14.
21. Liu T, Ramesh A, Ma Z, Ward SK, Zhang L, George GN, et al. CsoR is a novel Mycobacterium tuberculosis copper-sensing transcriptional regulator. Nat Chem Biol. 2007;3:60-8.
22. Uhía I, Galán B, Morales V, García JL. Initial step in the catabolism of cholesterol by Mycobacterium smegmatis mc2 155. Environ Microbiol. 2011;13:943-59.
23. Muñoz-Elías EJ, McKinney JD. Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence. Nat Med. 2005;11:638-44.
24. Gengenbacher M, Kaufmann SHE. Mycobacterium tuberculosis: success through dormancy. FEMS Microbiol Rev. 2012;36:514-32.
25. Takayama K, Wang C, Besra GS. Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis. Clin Microbiol Rev. 2005;18:81-101.
26. Lew JM, Kapopoulou A, Jones LM, Cole ST. TubercuList--10 years after. Tuberc Edinb Scotl. 2011;91:1-7.
27. Datta M, Via LE, Chen W, Baish JW, Xu L, Barry CE, et al. Mathematical model of oxygen transport in tuberculosis granulomas. Ann Biomed Eng. 2016;44:863-72.
28. Shi L, Sohaskey CD, Pfeiffer C, Datta P, Parks M, McFadden J, et al. Carbon flux rerouting during Mycobacterium tuberculosis growth arrest. Mol Microbiol. 2010;78:1199-215.
29. Baek S-H, Li AH, Sassetti CM. Metabolic regulation of mycobacterial growth and antibiotic sensitivity. PLoS Biol. 2011;9:e1001065.
30. Machová I, Snášel J, Zimmermann M, Laubitz D, Plocinski P, Oehlmann W, et al. Mycobacterium tuberculosis phosphoenolpyruvate Carboxykinase is regulated by redox mechanisms and interaction with Thioredoxin. J Biol Chem. 2014;289:13066-78.
31. Howell Wescott HA, Roberts DM, Allebach CL, Kokoczka R, Parish T. Imidazoles induce reactive oxygen species inMycobacterium tuberculosisWhich is not associated with cell death. ACS Omega. 2017;2:41-51.
32. Pethe K, Sequeira PC, Agarwalla S, Rhee K, Kuhen K, Phong WY, et al. A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy. Nat Commun. 2010;1:57.
33. Beste DJV, Espasa M, Bonde B, Kierzek AM, Stewart GR, McFadden J. The genetic requirements for fast and slow growth in mycobacteria. PLoS One. 2009;4:e5349.
34. Phong WY, Lin W, Rao SPS, Dick T, Alonso S, Pethe K. Characterization of phosphofructokinase activity in Mycobacterium tuberculosis reveals that a functional glycolytic carbon flow is necessary to limit the accumulation of toxic metabolic intermediates under hypoxia. PLoS One. 2013;8:e56037.
35. Piddington DL, Fang FC, Laessig T, Cooper AM, Orme IM, Buchmeier NA. Cu,Zn superoxide dismutase of Mycobacterium tuberculosis contributes to survival in activated macrophages that are generating an oxidative burst. Infect Immun. 2001;69:4980-7.
36. Huet G, Castaing J-P, Fournier D, Daffé M, Saves I. Protein splicing of SufB is crucial for the functionality of the Mycobacterium tuberculosis SUF machinery. J Bacteriol. 2006;188:3412-4.
37. Hatzios SK, Bertozzi CR. The regulation of sulfur metabolism in Mycobacterium tuberculosis. PLoS Pathog. 2011;7:e1002036.
38. Villela AD, Sánchez-Quitian ZA, Ducati RG, Santos DS, Basso LA. Pyrimidine salvage pathway in Mycobacterium tuberculosis. Curr Med Chem. 2011;18:1286-98.
39. Abdallah AM, Bestebroer J, Savage NDL, de Punder K, van Zon M, Wilson L, et al. Mycobacterial secretion systems ESX-1 and ESX-5 play distinct roles in host cell death and inflammasome activation. J Immunol Baltim Md. 1950;2011(187):4744-53.
40. Das C, Ghosh TS, Mande SS. In silico dissection of type VII secretion system components across bacteria: new directions towards functional characterization. J Biosci. 2016;41:133-43.
41. Dahl JL, Lau BD. The wag31 gene of Mycobacterium tuberculosis is positively regulated by the stringent response. FEMS Microbiol Lett. 2011;319:153-9.
42. Anuradha CM, Mulakayala C, Babajan B, Naveen M, Rajasekhar C, Kumar CS. Probing ligand binding modes of Mycobacterium tuberculosis MurC ligase by molecular modeling, dynamics simulation and docking. J Mol Model. 2010;16:77-85.
43. Chen Z, Hu Y, Cumming BM, Lu P, Feng L, Deng J, et al. Mycobacterial WhiB6 differentially regulates ESX-1 and the dos regulon to modulate granuloma formation and virulence in zebrafish. Cell Rep. 2016;16:2512-24.
44. Stapleton M, Haq I, Hunt DM, Arnvig KB, Artymiuk PJ, Buxton RS, et al. Mycobacterium tuberculosis cAMP receptor protein (Rv3676) differs from the Escherichia coli paradigm in its cAMP binding and DNA binding properties and transcription activation properties. J Biol Chem. 2010;285:7016-27.
45. Spagnolo L, Törö I, D'Orazio M, O'Neill P, Pedersen JZ, Carugo O, et al. Unique features of the sodC-encoded superoxide dismutase from Mycobacterium tuberculosis, a fully functional copper-containing enzyme lacking zinc in the active site. J Biol Chem. 2004;279:33447-55.
46. Feng S, Ollivier JF, Soyer OS. Enzyme sequestration as a tuning point in controlling response dynamics of Signalling networks. PLoS Comput Biol. 2016;12:e1004918.
47. Mahajan G, Mande SC. From system-wide differential gene expression to perturbed regulatory factors: a combinatorial approach. PLoS One. 2015;10:e0142147.
48. Bose T, Venkatesh KV, Mande SS. Computational analysis of host-pathogen protein interactions between humans and different strains of Enterohemorrhagic Escherichia coli. Front Cell Infect Microbiol. 2017;7:128.
49. Gonzalez AG, Naldi A, Sánchez L, Thieffry D, Chaouiya C. GINsim: a software suite for the qualitative modelling, simulation and analysis of regulatory networks. Biosystems. 2006;84:91-100.
50. Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M, Roth A, et al. STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 2013;41:D808-15.
51. Kuntal BK, Dutta A, Mande SS. CompNet: a GUI based tool for comparison of multiple biological interaction networks. BMC Bioinformatics. 2016;17:185.